Anti-tumor activity of a novel EGFR tyrosine kinase inhibitor against human NSCLC in vitro and in vivo
Author:
Publisher
Elsevier BV
Subject
Cancer Research,Oncology
Reference24 articles.
1. Cancer statistics;Jemal;CA Cancer J. Clin.,2006
2. Comparison of four chemotherapy regimens for advanced non-small-cell lung cancer;Schiller;New Engl. J. Med.,2002
3. Epidermal growth factor receptor gene and protein and gefitinib sensitivity in non-small-cell lung cancer;Cappuzzo;J. Natl. Cancer Inst.,2005
4. The EGFR family and its ligands in human cancer signaling mechanisms and therapeutic opportunities;Yarden;Eur. J. Cancer,2001
5. The epidermal growth factor receptor pathway and its inhibition as anticancer therapy;Janmaat;Drugs Today,2003
Cited by 12 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Identification and Validation of an Immune and Ferroptosis-Combined Index for Non–Small Cell Lung Cancer;Frontiers in Genetics;2021-11-30
2. Cetuximab and Doxorubicin loaded dextran-coated Fe3O4 magnetic nanoparticles as novel targeted nanocarriers for non-small cell lung cancer;Journal of Magnetism and Magnetic Materials;2019-07
3. The biology, function and clinical implications of exosomes in lung cancer;Cancer Letters;2017-10
4. Centipede Scolopendra suppresses cell growth in human epidermoid carcinoma cell A431;Bangladesh Journal of Pharmacology;2017-08-20
5. Design, synthesis, and biological evaluation of imidazo[1,2- b ]pyridazine derivatives as mTOR inhibitors;European Journal of Medicinal Chemistry;2017-03
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3